A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Clinical trial NCT03131453 · TERMINATED
Trial details
- NCT number
- NCT03131453
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2020-03-26
- Enrollment
- 1145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.